Copyright
©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 309-318
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.309
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.309
Table 1 Mast cells involved in non-allergic diseases in internal medicine.
| Disease | Evidence |
| Chronic obstructive | Mast cell hyperplasia in epithelia and |
| pulmonary disease | bronchial glands[2,3], tryptase and histamine |
| (COPD) | release in BALF[4] |
| Cor pulmonale | Mast cell hyperplasia in bronchial and |
| vascular tissues[5] | |
| Bronchiectasis | Increased numbers of degranulated mast |
| cells in lung tissue, and higher tryptase | |
| concentrations in BALF[6] | |
| Acute respiratory | Mast cell hyperplasia[7] and degranulation[8] |
| distress syndrome (ARDS) | |
| ronchiolitis obliterans- | Mast cell hyperplasia[9] and degranulation[10] |
| organizing pneumonia | |
| Cystic fibrosis | Mast cell hyperplasia[11] and |
| degranulation[12] in lung | |
| Interstitial lung diseases | Mast cell hyperplasia[13] and degranulation[14] |
| Silicosis | Mast cell hyperplasia[15] |
| Sarcoidosis | Mast cell hyperplasia[16], and |
| degranulation[17] in lung | |
| Lung cancer | Mast cell hyperplasia[18] |
| Tuberculosis | Mast cell degranulation[19] |
| Gastritis | Mast cell hyperplasia[20] and degranulation[21] |
| Peptic ulcer | Mast cell hyperplasia[22] and degranulation[23] |
| Hepatocellular | Mast cell hyperplasia[24] |
| carcinoma | |
| Ulcerative colitis | Mast cell hyperplasia[25,26] and degranulation[27] |
| Crohn’s disease | Mast cell hyperplasia[28] and degranulation[29] |
| Liver cirrhosis | Mast cell hyperplasia[30] |
| Hepatitis | Mast cell hyperplasia[31,32] |
| Pancreatitis | Mast cell hyperplasia and degranulation[33] |
| Atherosclerosis | Mast cell hyperplasia[34] |
| Myocardial infarction | Mast cell hyperplasia and degranulation[35,36] |
| Congenital heart disease | Mast cell hyperplasia and subtype change[37] |
| Myocarditis | Mast cell hyperplasia[38] |
| Cardiomyopathy | Mast cell hyperplasia[39] and degranulation[40] |
| Diabetes | Mast cell hyperplasia[41] |
| Thyroiditis | Mast cell hyperplasia[42] |
| Osteoporosis | Mast cell hyperplasia[43] |
| Glomerulonephritis | Mast cell hyperplasia[44] |
| Nephropathy | Mast cell hyperplasia[45] |
| Multiple sclerosis | Mast cell hyperplasia[46] |
| Rheumatoid arthritis | Mast cell degranulation[47] |
| Osteoarthritis | Mast cell hyperplasia[48] |
| Rheumatic arthritis | Mast cell hyperplasia[49] |
- Citation: He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004; 10(3): 309-318
- URL: https://www.wjgnet.com/1007-9327/full/v10/i3/309.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i3.309
